ATRC today
$56.40+$0.42 (+0.75%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minLeaning Bullish
5 minDescending Triangle
Daily trend turns down below $51.63
Key levels
Resistance$63.00
Resistance$57.98
Support$54.74
Support$51.63
Latest news & SEC filings
SEC FilingAtriCure, Inc. filed an insider trading report (Form 4)
NewsAtriCure insider sells company stock
AnalystCanaccord Genuity keeps Buy rating on AtriCure, lifts target to $67
All ATRC news →About AtriCure
AtriCure makes surgical devices for treating atrial fibrillation, managing the left atrial appendage, and easing pain after surgery. Its offerings include ablation clamps, pens, and cryoablation probes, along with the AtriClip system for closing off the left atrial appendage. The company reaches hospitals and clinics in the United States and parts of Europe, Australia, and Canada through its own sales team, and elsewhere via distributors.
Based on the company's 10-K filed Feb 19, 2026.
Nasdaq · Healthcare
AtriCure, Inc. (ATRC)
What Is the Price Target for ATRC?
SEPT Low Target
$50.00
SEPT Mid Target
$60.00
SEPT High Target
$68.00
Analyst Consensus
$60.00
Is ATRC a Buy or Sell Right Now?
Thesis
- •Revenue growing 14.9% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ATRC.
Start Free Trial →Is ATRC Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, PEG, Analyst Consensus
Fair Value
$42.78
51
Moat Score
NARROW
6/9
Piotroski Score
11.1
Altman Z-Score
What Is Smart Money Doing with ATRC?
Insider Signal
SELLING
0 buys / 4 sells (90d)
Congress Signal
BUYING
1 buys / 1 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| JOHNSON B KRISTINE | director | Sale | 2,452 | $143K | Nov 6, 2026 |
| Privitera Salvatore | officer | Sale | 8,404 | $546K | Nov 4, 2026 |
| Privitera Salvatore | officer | Sale | 4,519 | $271K | Sep 23, 2026 |
| Doraiswamy Vinayak | officer | Buy | 636 | $15K | Jun 30, 2026 |
| Dahlquist Karl S. | officer | Buy | 636 | $15K | Jun 30, 2026 |
| Prange Karen | director | Sale | 3,000 | $86K | May 20, 2026 |
| Nachman Shlomo | director | Buy | 6,144 | - | May 18, 2026 |
| Telman Deborah H | director | Buy | 6,144 | - | May 18, 2026 |
| Yuen Maggie | director | Buy | 6,144 | - | May 18, 2026 |
| GROVES REGINA E | director | Buy | 6,144 | - | May 18, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ATRC Growth Story
Revenue YoY
14.9%
3yr Revenue CAGR
17.4%
EPS Growth YoY
74.74%
FCF Growth YoY
6381.1%
Revenue Trend
STRONG
Dark Pool Trades for ATRC
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ATRC, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:25:08 | $55.84 | 10,906 | $$609K | BUY |
| 16:18:05 | $56.08 | 7,167 | $$402K | BUY |
| 15:54:56 | $56.34 | 1,296 | $$73K | MIDPOINT |
| 15:51:17 | $56.33 | 7,627 | $$430K | MIDPOINT |
| 14:56:20 | $56.65 | 1,043 | $$59K | BUY |
5 dark pool trades shown · $$1.6M preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for AtriCure, Inc. (ATRC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ATRC — frequently asked questions
What is ATRC stock price today?
AtriCure, Inc. (ATRC) is at $56.40, up 0.75% (+$0.42) at the Nov 13, 2026 close.
Why is ATRC stock moving today?
Latest ATRC news — Nov 10, 2026: AtriCure, Inc. filed an insider trading report (Form 4) · Nov 5, 2026: AtriCure insider sells company stock
What is the ATRC price target?
The average analyst price target for ATRC is $60.00, ranging from $50 to $68, based on 7 analysts. Latest: Citizens maintains on Oct 21, 2026.
What do analysts rate ATRC?
Analyst ratings for ATRC: 0 Buy, 8 Hold, 0 Sell — consensus Hold.
Did ATRC beat earnings?
ATRC last reported on Jul 23, 2026: EPS $0.18 vs -$0.00 expected — a beat of 10688.2%.
What is ATRC's P/E ratio?
ATRC trades at a P/E of 289.5 vs a Healthcare average of 17.8.
Does ATRC pay a dividend?
ATRC does not currently pay a dividend.
How much debt does ATRC have?
AtriCure, Inc. reported $61M of debt and $168M of cash (Jun 30, 2026).
What are ATRC support and resistance levels?
Support: $54.74, $51.63, $47.06. Resistance: $57.98, $63.00, $68.58.
What are insiders doing with ATRC?
Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.
What is the latest news on ATRC?
Nov 10, 2026: AtriCure, Inc. filed an insider trading report (Form 4) · Nov 5, 2026: AtriCure insider sells company stock · Nov 4, 2026: Canaccord Genuity keeps Buy rating on AtriCure, lifts target to $67